Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
115 Cards in this Set
- Front
- Back
Drug of choice for CMV?
|
Ganciclovir, valganciclovir
|
|
Drug of choice for HSV, VZV?
|
Acyclovir
|
|
Drug of choice for HBV?
|
IFN-α, lamivudine
|
|
Drug of choice for HCV?
|
IFN-α
|
|
Drug of choice for Influenza A/B?
|
Oseltamivir
|
|
NRTIs?
|
Zidovudine
Abacavir, didanosine, emtricitabine, lamivudine, stavudine, zalcitabine |
|
NNRTIs?
|
Delavirdine
Efavirenz, nevirapine, tenofovir |
|
Protease Inhibitors?
|
Indinavir
Amprenavir, atazanavir, indinavir, lopinavir, nelfinavir, ritonavir, saquinavir |
|
Fusion inhibitors?
|
Enfuvirtide
|
|
Antiherpes drugs?
|
Acyclovir
Ganciclovir Cidofovir Foscarnet Vidarabine Idoxuridine, Trifluridine Fomivirsen |
|
general MOA of antiherpes drugs?
|
antimetabolites bioactivated via viral or host cell kinases to form compounds that inhibit viral DNA polymerases
|
|
MOA of acyclovir?
|
activated to acyclovir triphosphate, which blocks viral DNA synthesis
(competitive substrate for DNA polymerase, also leads to chain termination after incorporation into viral DNA) |
|
mechanism of resistance to acyclovir?
|
virus lacks thymidine kinase
(involved in the initial viral-specific phosphorylation of acyclovir) |
|
toxic effects of parenteral acyclovir?
|
delirium, tremor, sezures, hypotension, nephrotoxicity
|
|
which drug is converted to acyclovir by hepatic metabolism, reaches plasma levels 3-5X greater than acyclovir, and has longer duration?
|
Valacyclovir
|
|
which drug is activated by viral thymidine kinase and inhibits DNA polymerase but doesn't cause chain termination?
|
Penciclovir
|
|
Which of the acyclovir congeners have activity against TK- strains of HSV?
|
none of them
|
|
MOA of docosanol?
|
inhibits fusion btwn HSV envelope and plasma membranes (prevents viral entry and subsequent replication)
|
|
MOA of ganciclovir?
Resistance? |
guanine derivative, triphophorylated to form a nucleotide that inhibits DNA polymerases of CMV and HSV and causes chain termination.
HSV: absence of TK; CMV: mutations in viral phosphotransferase and viral DNA polmerases |
|
Which drug has high oral bioavailability and has decreased usage of IV ganciclovir in CMV?
|
Valganciclovir (prodrug of ganciclovir)
|
|
Clinical use of ganciclovir and valganciclovir?
|
prophy and tx of CMV retinitis and other CMV infxns in immunocompromised pts
|
|
toxic effects of ganciclovir?
|
leukopenia, thrombocytopenia, mucositis, hepatic dysfxn, seizures
|
|
MOA of cidofovir?
Resistance? |
activated by host cell kinases to diphosphate that inhibits DNA polymerases of HSV, CMV, adenovirus and HPV
mutations in DNA polymerase gene |
|
Toxic effects of cidofovir?
|
Nephrotoxicity (IV administered and metabolized by kidneys, adjust dose in proportion to CrCl),
Probenicid decreases tubular secretion and reduces nephrotoxicity |
|
MOA of Foscarnet?
Resistance? |
*Does not require phophorylation for action;
Inhibits viral RNA polymerase, DNA polymerase, and HIV reverse transcriptase point mutations in DNA polymerase gene |
|
Clinical use of foscarnet?
|
alternative prophy/tx of CMV, esp. against TK- strains
inhibits TK- HSV, esp. in AIDS pts |
|
Toxic effects of foscarnet?
|
*Effects are severe*
Nephrotoxicity w/ electrolyte disturbances (esp hypocalcemia) GU ulcers CNS (HA, hallucinations, seizures) |
|
Antiherpes drug that is an adenine analog, is active against HSV, VZV, and CMV, used topically for herpes keratitis, is rapidly metabolized and has marked toxicity?
|
Vidarabine
|
|
Toxic effects of Vidarabine?
|
(with systemic use)
GI upset, paresthesias, tremor, convulsions, hepatic dysfxn |
|
Antiherpes drugs that are pyrimidine anaolgs, used topically in herpes keratitis, but are too toxic for systemic use?
|
Idoxuridine and trifluridine
|
|
MOA of Fomivirsen?
|
antisense oligonucleotide that binds mRNA of CMV, inhibiting early protein synthesis
|
|
Clinical use of Fomivirsen?
|
injected intravitreally for CMV retinitis
|
|
current ideal tx regimen for HIV?
|
tx with 3 or more anti-retroviral drugs before onset of sx, if possible
|
|
MOA of NRTIs?
|
activated by host kinases to triphosphates which competitively inhibit binding of natural nucleotides to dNTP binding site of rev transcriptase and also chain terminate (lack 3'-hydroxyl, preventing attachment of next nucleotide)
|
|
problem with NRTIs?
|
resistance emerges rapidly if used as single agents (via mutations in pol gene)
|
|
Features of Abacavir?
Toxic effects? |
NRTI: guanosine analog; good oral bioavail; 12-24h 1/2 life; resistance develops slowly
Hypersensitivity rxns (sometimes fatal) in 5% of HIV pts |
|
Which NRTI causes pancreatitis in alcoholic pts and pts with hypertriglyceridemia?
|
didanosine
|
|
Toxic effects of didanosine?
|
peripheral neuropathy
diarrhea hepatic dysfxn hyperuricemia CNS effects |
|
Which NRTI has once-daily dosing but is contraindicated in pregnancy, children, and pts with hepatic or renal dysfxn?
|
Emtricitabine
|
|
Toxic effects of Emtricitabine?
|
asthenia
GI upset HA hyperpigmentation of palms and/or soles |
|
which NRTI is used in HBV infection in addition to HAART?
|
Lamivudine
|
|
toxic effects of Lamivudine?
|
usually mild; GI upset, HA, insomnia, fatigue
renal metabolism requires dosage adjustment in renal insufficiency |
|
which NRTI penetrates most tissues, including CNS, but causes peripheral neuropathy, esp w/ co-administration of didanosine or zalcitabine?
|
Stavudine
(Zalcitabine also causes peripheral neuropathy) |
|
Which NRTI has the greatest incidence of lactic acidosis w/ hepatic steatosis?
|
Stavudine
|
|
What type of protein is Tenofovir?
MOA? |
Nucleotide
Acts like NRTIs to competitively inhibit reverse transcriptase and cause chain termination |
|
what side effect is mutual to all NRTIs?
|
lactic acidosis and severe hepatomegaly with steatosis
|
|
What antiviral may inhibit the renal excretion of acyclovir and ganciclovir?
|
Tenofovir
|
|
names of NRTI's?
|
-ines and -vudines (and Abacavir)
|
|
Names of PIs?
|
-avirs
|
|
Toxic effects of Tenofovir?
|
GI upset, asthenia, HA, acute renal flr (rare) and Fanconi's syndrome (rare)
|
|
benefit of Zalcitabine?
toxic effects? |
high oral bioavailability
can increase toxicity of nephrotoxic drugs, peripheral neuropathy, pancreatits, esophageal ulcers, stomatitis, arthralgias |
|
Which NRTI is distributed to most tissues including CNS and is eliminated via hepatic metabolism and renal excretion (must reduce in pts with cirrhosis and uremic pts)?
|
Zidovudine
|
|
Primary toxic effect of Zidovudine?
|
bone marrow suppression (additive with other myelosuppressive drugs) --> anemia, neutropenia
|
|
which drugs increase the plasma levels of Zidovudine?
which drugs increase the clearance? |
azole antifungals and protease inhibitors
Rifampin |
|
MOA of NNRTIs?
|
Block viral nucleic acid synthesis by binding to a site on reverse transcriptase (different than the site of NRTIs) do not require activation by phosphorylation, and do not compete with nucleoside triphospates
|
|
mechanism of resistance to both NRTIs and NNRTIs?
|
mutations in the pol gene
|
|
NNRTIs?
|
Delavirdine
Efavirenz Nevirapine Tenofovir |
|
What drugs decrease the blood levels of Delavirdine?
What drugs increase the blood levels? |
antacids, ddI, phenytoin, rifampin, nelfinavir
azole antifungals, macrolides |
|
Major side effects with Delavirdine?
|
drug interactions because it is metabolized by CYP3A4 and CYP2D6
Skin rash |
|
Which NNRTI can be given once daily?
|
Efavirenz
|
|
major problem with NNRTIs?
|
drug interactions b/c metabolized by CYP enzymes
|
|
what should you tell a patient to do to increase the bioavailability of Efavirenz?
|
take with fatty foods
|
|
Toxic effects of Efavirenz?
|
CNS dysfxn
skin rash elevated plasma cholesterol teratogenic |
|
Which NNRTI has good oral bioavailability, penetrates most tissues (CNS) and has a half-life > 24h?
|
Nevirapine
|
|
Which NNRTI is effective in preventing HIV vertical transmission?
|
Nevirapine (given as single dose to mothers at onset of labor and to neonate)
|
|
Toxic effects of Nevirapine?
|
skin rash
Stevens-Johnson syndrome and severe toxic epidermal necrolysis |
|
What drugs increase the blood levels of NNRTIs?
What drugs decrease them? |
cimetidine and macrolide abx
enzyme inducers (e.g. Rifampin) |
|
MOA of PIs?
|
Inhibit HIV-1 aspartate protease enzyme that is used to cleave precursor polyproteins to form the final structural proteins of the mature virion core
|
|
Resistance mechanism against PIs?
|
multiple point mutations in pol gene
|
|
Use of PIs in AIDS are most commonly in combinations with what drugs?
|
Reverse transcriptase inhibitors (NNRTIs and NRTIs)
|
|
which PI has the most pronounced inhibitory effect on CYP3A4?
|
Ritonavir
|
|
Side effect of all PIs?
|
CHO and lipid metabolism disorders (hyperglycemia, insulin resistance or hyperlipidemia with altered body fat distribution)
lipid-regulating proteins have active sites similar to HIV protease and may be thus inhibited |
|
The absorption of which PI is inhibited by fatty foods?
|
Amprenavir/fosamprenavir
|
|
Toxic effects of amprenavir/fosamprenavir?
|
GI upset, paresthesias, rash (sometimes severe)
Cross-allergenicity with sulfonamides |
|
Which PI can be given once daily but must not be taken simultaneously with antacids?
|
Atazanavir
|
|
Toxic effects of Atazanavir?
|
GI upset, peripheral neuropathy, rash, hyperbilirubinemia, prolonged QT interval (at high dose)
|
|
Which PI is the only one NOT associated with dyslipidemias, fat redistribution or a metabolic syndrome?
|
Atazanavir
|
|
Which PI has more common occurrence of insulin resistance?
|
Indinavir
|
|
Which PI can cause hyperbilirubinemia and kidney stones, in addition to nausea, diarrhea and thrombocytopenia?
|
Indinavir
|
|
Which PIs are given together because one enhances the pharmacokinetics of the other by inhibiting its CYP3A metabolism?
|
Lopinavir/ritonavir
(ritonavir inhibits CYP3A to enhance lopinavir, can give smaller dose) |
|
Which PI is the safest for pregnancy?
|
Nelfinavir
|
|
Which PI is characterized by increased oral absorption in the presence of food and a short half-life?
|
Nelfinavir
|
|
Adverse effects of Nelfinavir?
|
Diarrhea
|
|
Which drugs inhibit CYP3A4?
|
Amiodarone, azoles, cimetidine, erythromycin, clarithromycin, cyclosporine, diltiazem, fluoroquinolones, indinavir, ritonavir, grapefruit juice, PI's, metronidazole, quinine, SSRIs, tacrolimus
|
|
Which drugs induce or enhance the activity of CYP3A4?
|
Barbiturates, carbamazepine, corticosteroids, efavirenz, phenytoin, rifampin, troglitazone
|
|
Toxic effects of Ritonavir?
|
bitter taste, GI upset, paresthesias, elevations of liver enzymes, inhibits metabolism of many drugs
|
|
Toxic effects of Saquinavir?
How can these effects be lessened? |
nausea, diarrhea, dyspepsia, rhinitis
GI effects reduced by combination with ritonavir, allowing once-daily dosing |
|
MOA of Enfuvirtide?
|
binds to gp41 subunit of viral envelope glycoprotein, inhibiting fusion of viral and host cellular membranes
NOT metabolized by CYP450 |
|
Mechanism of resistance to Enfuvirtide?
|
mutations in env gene
|
|
Which anti-HIV drug is administered SQ with other anti-HIV drugs in patients with persistent HIV-1 replication despite ongoing therapy?
|
Enfuvirtide
|
|
What are the anti-influenza agents?
|
Amatadine/Rimantadine and Osetamivir/Zanamivir
|
|
MOA of Amantidine/Rimantidine?
|
prevent uncoating of Influenza A virus after penetration by binding to and inhibiting protein M2, which acts as a proton pump to acidify and activate viral RNA transcriptase
|
|
What are Amantidine and Rimantadine effective against?
|
Influenza A (NOT B)
|
|
Toxic effects of Amatidine/Rimantidine?
|
GI upset, dizziness, ataxia, slurred speech
Amantidine requires dosage adjustment in renal failure |
|
MOA of Oseltamivir and Zanamivir?
|
Inhibit neuraminidases of influenza A and B, which cleave sialic acid from viral proteins and surface proteins of host cells to release virions, preventing viral spread
|
|
When are Oseltamivir and Zanamivir most effective?
|
if used within 24h after onset of sxs
|
|
Toxic effects of Oseltamivir and Zanamivir?
|
Oseltamivir: GI sxs
Zanamivir: cough, sore throat, bronchospasm in asthmatics |
|
What agents are used to suppress viral hepatitis?
|
IFN-α
Adefovir dipivoxil Lamivudine Entecavir Ribavirin |
|
MOA of IFN-α?
|
cytokine that increases activity of JAK-STAT receptors that increase txn of antiviral proteins, esp. host ribonuclease that degrades viral mRNA
also promotes formation of NK cells |
|
When is IFN-α useful against HBV?
When is it useful against HCV? |
Used individually or in combination with Lamivudine against chronic HBV
Used in combination with Ribavirin to reduce the progression from acute to chronic HCV |
|
What is IFN-α used against?
|
HBV, HCV, Kaposi sarcoma, HPV, preventing dissemination of VZV in cancer pts, reduces CMV shedding after renal txp
|
|
Toxic effects of IFN-α?
|
GI upset, flulike syndrome, neutropenia, profound fatigue and myalgia, alopecia, reversible hearing loss, thyroid dysfxn, mental confusion, severe depression
|
|
MOA of Adefovir dipivoxil?
Clinical use? |
activated by phosphorylation, competitively inhibits HBV DNA polymerase and results in chain termination
suppresses HBV replication, improves liver histology and fibrosis, used against lamivudine-resistant strains of HBV |
|
Toxic effects of Adefovir dipivoxil?
|
nephrotoxicity, lactic acidosis, severe hepatomegaly w/ steatosis
|
|
Clinical uses of Lamivudine?
|
nucleoside inhibitor of HIV reverse transcriptase, also active in chronic HBV; longer half-life in HBV-infected cells than in HIV-infected, is nontoxic when used as monotherapy
|
|
What increases the risk of pancreatitis in an HBV pt being treated with Lamivudine?
|
Co-infection with HIV
|
|
MOA of Entecavir?
|
guanosine nucleoside, inhibits HBV DNA polymerase (reverse transcriptase)
|
|
Toxic effects of Entecavir?
|
HA, dizziness, fatigue, nausea
cross-resistance with Lamivudine |
|
MOA of Ribavirin?
|
Inhibits guanosine triphosphate (purine nucleotide) formation, prevents capping of viral mRNA, blocks RNA-dependent RNA polymerases
|
|
Clinical use of Ribavirin?
|
prevents replication of influenza A/B, parainfluenza, RSV, paramyxoviruses, HCV, HIV
Not effective as monotherapy, used with IFN-α in chronic HCV in pts with compensated liver dz |
|
Toxic effects of Ribavirin?
|
Hemolytic anemia (systemic use)
Conjunctival and bronchial irritation (aerosolic use) Teratogenic |
|
which of the systemic antiherpes drugs do not require activation by thymidine kinase?
|
Cidofovir, Foscarnet
|
|
which of the antiherpes drugs inhibit DNA polymerase but do not cause chain termination?
|
Penciclovir, Famciclovir
|
|
which antivirals are contraindicated in pregnancy?
|
Emtricitabine (propylene glycol)
Amprenavir/Fosamprenavir (propylene glycol) Vidarabine Delavirdine Efavirenz Ribavirin |
|
What side effect do Acyclovir and Indinavir have in common?
|
Kidney problems -
Acyclovir is very insoluble in urine and can crystallize and cause hematuria; Indinavir can cause kidney stones. Adequate hydration necessary for both |